ArticleMovement disorders clinical practice2022

Nicotinamide Adenine Dinucleotide Supplementation in Parkinson's Disease: A Potential Disease-Modifying Agent Targeting Multiple Pathways.

Viviana Alexandra Martínez-Villota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.